Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
New Blog! $KDRHD to $NTVA: Intiva BioPharma (@IntivaBiopharma) is Going Public!
http://ownthefloat.com/index.php/2017/12/03/kdrhd-to-ntva-intiva-biopharma-is-going-public/
Intiva's CEO is an Advisor to $OWCP and Board Member of CannRX in Israel.
This could be a bad ass #MarijuanaStock.
Indeed, $OWCP has been a hold for many but also a great stock for traders.
2018 and 2019 will see more and more growth, based on what they revealed in their timelines with human trials and FDA hopes.
Lots of due diligence at OwnTheFloat.com for anyone who cares, but the chart speaks volumes for people just wanting to trade and flip in a day, week, or month.
Yes, sir! Very awesome!
I can't believe I missed that the first time around. I have updated the Blog.
It's going to take progress and patience for a ~$3 Billion Market Cap, but it's far from impossible. Look at GWPH.
Yes, sir. I did just update that after doing some proof-reading again.
Glad to see people are actually reading the blogs though! LOL. Thanks for proving that. :)
Yes, I was re-reading it again (proof reading) and noticed that error. It's been updated. :)
$OWCP may be worth another look, guys. Currently fairly stable around $0.32 with a previous 52-week High of $3.23 (February 22nd). The company, it's research & development, and sales timeline are MUCH better NOW than back in February.
Check out this blog -- "Breaking Down the Updated #Investor Presentation" --
http://ownthefloat.com/index.php/2017/11/12/owcp-breaking-down-the-updated-investor-presentation/
$OWCP, under the leadership of an experienced Biotech exec (Dr. Stanley Hirsch), has put out some nice timelines.
They are expected to cross-list on a Canadian exchange VERY SOON, at which point we feel many updates will come. Especially when some of them were touched on in the latest Investor Presentation.
Many are expecting sales to start in Europe soon with Canada to follow soon after. This will be dispensary type sales, of course, as they continue on with Studies and eventually try for FDA Approval.
$OWCP may be worth another look, guys. Currently fairly stable around $0.32 with a previous 52-week High of $3.23 (February 22nd). The company, it's research & development, and sales timeline are MUCH better than back in February.
Why would it be unreasonable to think $3.52+ can't happen again in the coming weeks or months (depending on the release of official PRs)?
Check out this blog -- "Breaking Down the Updated #Investor Presentation" -- http://ownthefloat.com/index.php/2017/11/12/owcp-breaking-down-the-updated-investor-presentation/
$OWCP, under the leadership of an experienced Biotech exec (Dr. Stanley Hirsch), has put out some nice timelines.
They are expected to cross-list on a Canadian exchange VERY SOON, at which point we feel many updates will come. Especially when some of them were touched on in the latest Investor Presentation.
Many are expecting sales to start in Europe soon with Canada to follow soon after. This will be dispensary type sales, of course, as they continue on with Studies and eventually try for FDA Approval.
$OWCP may be worth another look, guys. Currently fairly stable around $0.32 with a previous 52-week High of $3.23 (February 22nd). The company, it's research & development, and sales timeline are MUCH better than back in February.
Check out this blog -- "Breaking Down the Updated #Investor Presentation"
http://ownthefloat.com/index.php/2017/11/12/owcp-breaking-down-the-updated-investor-presentation/
$OWCP, under the leadership of an experienced Biotech exec (Dr. Stanley Hirsch), has put out some nice timelines.
They are expected to cross-list on a Canadian exchange VERY SOON, at which point we feel many updates will come. Especially when some of them were touched on in the latest Investor Presentation.
Many are expecting sales to start in Europe soon with Canada to follow soon after. This will be dispensary type sales, of course, as they continue on with Studies and eventually try for FDA Approval.
Can't wait for this stock to be "full blown ready". :)
Friedland is definitely going to kick some ass in this space.
$OWCP: Breaking Down the Updated Investor Presentation
http://ownthefloat.com/index.php/2017/11/12/owcp-breaking-down-the-updated-investor-presentation/
Absolutely. Agree 100%.
I've not once "been scared" during this wait. :)
The biggest difference between the documents is they now put a check in the box that says they are NOT a Shell company.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [ ] No [X]
I uploaded the wrong picture. I've updated the OwnTheFloat.com article.
Differences in Amended 10-Q Report on October 10th, 2017 posted here:
http://ownthefloat.com/index.php/2017/10/10/owcp-differences-in-amended-10-q-report-on-october-10th-2017/
I've highlight all the changes to the Amended 10-K here:
http://ownthefloat.com/index.php/2017/10/06/owcp-differences-on-amended-10-k-on-october-6th-2017/
They aren't trying to pump their stock. What's the point in that? They're not diluting or selling.
They're building something that takes time and they know what they have... They know in time, it'll be well worth it.
Yeah, pretty gross, huh? Haha. Was a solid stock for 30 years and then... Drop!
OWCP 8K Breakdown Blog: Letter from the Chairman to Shareholders
http://ownthefloat.com/index.php/2017/09/13/owcp-letter-from-the-chairman-to-shareholders/
Nice thing to take away from this, in my opinion, was Dr. Hirsch's deal between Foamix and Bayer -- which reported $927,000 in royalty payments in Q1 of 2017 alone for Foamix.
(Source: http://www.prnewswire.com/news-releases/foamix-reports-first-quarter-2017-financial-results-and-provides-business-update-300454202.html)
Eeeeasily explained with their collaboration with Sheba Hospital in Israel and the fact that EVERYBODY is paid a grossly small salary (if any), but instead are paid with shares.
So, again, their only chance of getting money out of OWCP once their 2 year restriction is up is SUCCESS.
I prefer that over a bloated salary of a full time employee.
What else you got?
(Not that I'll be around to reply. I can only handle so much.)
Yes, an ACCUSATION. I've had friends that were accused of things where the lady later admitted she was lying -- it was a bad breakup ordeal.
While I won't say SHE is lying, I'm also saying an ACCUSATION isn't PROOF of GUILT. There has been NOTHING MORE about this since the accusation.
No charges were filed or anything of the sort. Thus, can we really hold it over his head?
AND! Does it have ANYTHING to do with his ability as a Medical Cannabis doctor who was the HEAD of the Israeli Medical Cannabis division beyond 10 years.
Dr. Baruch is a REAL DEAL Medical Cannabis research doctor.
Yes, truly amazing indeed. NON-TOXIC Financing compared to the typical CONVERTIBLE NOTES that you see in the OTC.
These private, accredited investors chose to wire tens or hundreds of thousands of dollars to OWCP knowing they COULD NOT SELL for 6 months.
They did get a slight discount on the share price as a result. That's very common.
What's your point?
Remember, OWCP started 2017 trading at $0.1815... So, $0.17 wasn't such a steep discount.
This is now the result of a LAWSUIT between OWCP and the Law Firm that represented them for this bad deal.
This is the only reason OWCP ever dipped below $0.01... Many of us are thankful for this "mess up".
Yeah? Because Medmar wasn't granted a Marijuana License from Maryland.
Big deal?
The answer to your question can be understood looking at the Condensed Consolidated Statements of Cash Flows. The total G&A was $1,401,000 -- deduct Amortization of Services Receivable $179,000 plus Stock-based compensation $1,058,000 so actual expenses were $164,000.
I hope it answers your question. The guys are working on a very minimum wages and expenses, but will be rewarded IN THE FUTURE upon success of the company.
Also, if you look into and learn about Israel Research, you'll see it's FAR LESS to do research on this type of thing there compared to the USA.
OWCP will absolutely return to $2 again.
No reason we won't have a timeline for sales in the coming months, results published (for the scientific community, investors got results in May), progress and timeline on Tablet, and success of Multiple Myeloma.
Smart people would be adding here. Wish I could. I'll book mark this post to refer back to in a few months.
http://www.foamix.co.il/ir.asp?nodeID=554
He's the CHAIRMAN of a NASDAQ traded company!
Is it September yet?
This company and it's shareholders will be in a better place come September, I imagine.
I strongly suspect we'll have a few decent updates through August and hopefully some stellar news on Multiple Myeloma by end of September -- as that's what the initial PR stated.
Waiting. Holding. Nothing has changed for me.
Can't wait for November and beyond, actually. CAPITAL GAINS on profits at new 52-week highs. Eff $3.23/share.
$OWCP was issued a BUY Alert at $0.49 with $1.93 target from AmericanBulls.com.
https://www.americanbulls.com/SignalPage.aspx?lang=en&Ticker=OWCP
That's based on technicals alone, not the catalysts/updates we can expect -- starting any day again. Lots of updates coming about the Topical Cream line-up, possible partnerships with manufacturing & distribution, sublingual tablet, multiple myeloma study to be completed in Q3, etc.
$OWCP was issued a BUY Alert at $0.49 with $1.93 target from AmericanBulls.com.
https://www.americanbulls.com/SignalPage.aspx?lang=en&Ticker=OWCP
That's based on technicals alone, not the catalysts/updates we can expect -- starting any day again.
Here's an actual intelligent response from an actual Patent Attorney, not an anonymous iHub user:
http://ownthefloat.com/index.php/2017/04/12/owcp-the-truth-about-the-patent-process/
You're welcome to e-mail Joe directly for more information.
Boom! You're not alone.
I know many folks talk like OTC is all scams, but there are plenty of OTC QB and OTC QX companies that do legit business and profit heavily.
OTC Pink is 99% scams and OWCP is not OTC Pink. Big difference.
I, too, invested in what this company CAN accomplish in time. I wrote a blog back in February talking about "My Plan For Selling" -- http://ownthefloat.com/index.php/2017/02/05/owcp-my-plan-for-selling/
My opinion is still very much the same. I'm excited to hear how the Multiple Myeloma stuff goes towards end of Q3.
Mediq relationship, the new (more experienced) CFO, the filing of a patent(s) in USA and Europe... They're all more obvious signs that OWCP is a real-deal company and will soon be a Revenue generating, profitable company.
Well, the ride isn't over. Just ran into a flat tire situation. We'll get that patched up and be back on the freeway again.
Again... Many POSITIVE updates that are far more valuable than anything that caused it to run to $1.00, $2.00, and $3.00 the last time.
Beautiful, sir. Well done.
I don't doubt it can trickle lower... Doesn't mean I understand the rationale.
Lots and lots of "longs" said they were fine waiting until Q4 or even into 2018 for OWCP to finish doing their thing with the Tablet and the Multiple Myeloma study... But then they freak out and think about selling when the price drops "for NO real reason".
The price isn't dropping because OWCP stopped doing research. The price isn't dropping because the CEO was arrested for a scam.
NOTHING CHANGED (negatively) WITH THE COMPANY.
They added a CFO with more experience running $100M companies and filed for Patents in the USA and Europe. Sounds like positive changes.
So, how far is it dropping?
The catalysts in play will certainly send it right back up in due time.
So, he's on the board at TMPS as well as COWEN Group. :)
Makes sense. This stock is so obviously worth more than $0.35. It's stupid to be under $1.00...
I couldn't tell you. I don't even care to watch day to day B.S. drama with the stock, because I feel confident in what I own and feel I'll be rewarded later in the year.
It's fairly obvious this is a legit operation. I hope Cross Listing with Canada exchange can help too with less manipulation.
What about the person who BOUGHT the 105,000 shares? I assume they have more of a clue than the impatient individual that sold.
Guess I'll have to wait for next week to see 0.79+ now, huh? Wishful thinking not fulfilled. Oh well. :)
Enjoy your weekend, everyone! I'm heading to the pool.